NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1588977102 MD
Verify on CMS → Saraswathi Saiprasad, MD
Endocrinology, Diabetes & Metabolism Physician in Fort Worth, Texas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,852 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
520
Medicare Part D claims · 157 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
38%
generic claims · 45% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$618.42
28 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Saraswathi Saiprasad, MD filed 520 Medicare Part D claims in 2023 as a Endocrinology, Diabetes & Metabolism Physician in Fort Worth, Texas, prescribing 38% generic.
- 520
- Part D claims, 2023
- 38%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Saraswathi Saiprasad, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
520 Top 34% higher than 66% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
✓
Board certification likely (heuristic, not verified)
Saraswathi Saiprasad, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Saraswathi Saiprasad, MD?
Quality data not reportedPrimary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
520 80% vs specialty avg
Specialty distribution in Texas
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Texas providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Endocrinology, Diabetes & Metabolism Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Saraswathi Saiprasad, MD appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding MD credentials at 1250 8TH AVE STE 650, Fort Worth, TX, 76104, with a listed phone of (817) 912-9570. NPI 1588977102 was issued on 07/24/2010.
Medicare Part D records for calendar year 2023 show 520 prescription claims written by this provider, covering 157 Medicare beneficiaries and totaling roughly $277K in drug spend, split 45% brand-name and 38% generic by claim count.
Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1588977102 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 07/24/2010 |
Hospital and facility affiliations
Facilities where Saraswathi Saiprasad, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Healthtexas Provider Network
Fort Worth, TX
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Saraswathi Saiprasad, MD. Source: openpaymentsdata.cms.gov.
Total received
$618
Largest payer
Insulet Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Texas TMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Saraswathi Saiprasad, MD. To verify Saraswathi Saiprasad, MD's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Saraswathi Saiprasad, MD - brand share 45.0%
Endocrinology, Diabetes & Metabolism Physician average
45% brand-name claims vs 38% generic, on 520 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
520
Total Claims
$277K
Total Drug Cost
157
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,175
- Total Day Supply
- 34,759
- Brand vs Generic
- 45% brand / 38% generic
- Brand Drug Cost
- $236K
- Generic Drug Cost
- $6K
Patient Demographics
- Average Patient Age
- 66.9 years
- Avg HCC Risk Score
- 1.72
- Gender Split
- 69% female / 31% male
- Age Distribution
- <65: 39, 65-74: 83, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Saraswathi Saiprasad, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
72 claims
- Atorvastatin Calcium
Atorvastatin Calcium
45 claims
- Trulicity
Trulicity
32 claims
- Jardiance 23
Jardiance
23 claims
- Methimazole 20
Methimazole
20 claims
- Ozempic 18
Ozempic
18 claims
- Metformin Hcl 17
Metformin Hcl
17 claims
- Novolog Flexpen 15
Novolog Flexpen
15 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 72 |
| Atorvastatin Calcium | 45 |
| Trulicity Dulaglutide | 32 |
| Jardiance Empagliflozin | 23 |
| Methimazole | 20 |
| Ozempic Semaglutide | 18 |
| Metformin Hcl | 17 |
| Novolog Flexpen Insulin Aspart | 15 |
| Tresiba Flextouch U-200 Insulin Degludec | 15 |
| Lantus Solostar "Insulin Glargine | N/A |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in TX →
All providers in Texas →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Saraswathi Saiprasad, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider
Saraswathi Saiprasad, MD's 520 claims are below the specialty average of 2,639.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Saiprasad.
Dr. Nicola Abate
MD
Baytown, TX
Dr. Jessica Abramowitz
MD
Dallas, TX
Dr. Layla Abushamat
M.D., M.P.H.
Houston, TX
Dr. Luis Acosta
MD
Houston, TX
Dr. Stefanie Addington
M.D.
Frisco, TX
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Texas medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Endocrinology, Diabetes & Metabolism Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Texas
Frequently Asked Questions
What is Saraswathi Saiprasad, MD's specialty? ▼
Saraswathi Saiprasad, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Fort Worth, Texas. Credentials: MD.
How much does Saraswathi Saiprasad, MD prescribe under Medicare Part D? ▼
In 2023, Saraswathi Saiprasad, MD wrote 520 Medicare Part D claims totaling $277K in drug costs for 157 beneficiaries.
Where is Saraswathi Saiprasad, MD located? ▼
Saraswathi Saiprasad, MD is located at 1250 8TH AVE STE 650, Fort Worth, TX, 76104. Phone: (817) 912-9570.
What is Saraswathi Saiprasad, MD's NPI number? ▼
Saraswathi Saiprasad, MD's National Provider Identifier (NPI) is 1588977102, issued on 07/24/2010.
Does Saraswathi Saiprasad, MD prescribe more brand-name or generic drugs? ▼
Saraswathi Saiprasad, MD's prescribing is 45% brand-name and 38% generic drugs by claim count, with $236K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does Saraswathi Saiprasad, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Saraswathi Saiprasad, MD's most frequently prescribed drugs include Levothyroxine Sodium, Atorvastatin Calcium, Trulicity. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Saraswathi Saiprasad, MD accept Medicare? ▼
Saraswathi Saiprasad, MD appears in CMS Medicare data with 520 Part D claims and 157 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Saraswathi Saiprasad, MD's credentials? ▼
Saraswathi Saiprasad, MD's NPI is 1588977102 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.